• A Matsushima, S Takakura, M Yamamoto, Y Matsumura, M Shirano, M Nagao, Y Ito, Y Iinuma, T Shimizu, N Fujita, and S Ichiyama.
• Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin-Kawaharacho, Sakyo, Kyoto, 6068507, Japan. akimat@kuhp.kyoto-u.ac.jp
• Eur. J. Clin. Microbiol. Infect. Dis. 2012 Jun 1; 31 (6): 1095-100.

AbstractThe purpose of this investigation was to control the post-outbreak prevalence of vancomycin-resistant enterococci (VRE) in the affected Kyoto region. The study period was from 2005 to 2010. Faecal samples were subjected to VRE screening, and vancomycin resistance genes were detected by polymerase chain reaction (PCR). The genotype was determined by pulsed-field gel electrophoresis (PFGE) of genomic DNA digested with SmaI and by multilocus sequence typing (MLST). A VRE control programme was established in 2006, consisting of a laboratory-based faecal VRE screening system, annual surveillance of hospital inpatients and the promotion of adequate infection control measures. vanA-Enterococcus faecium, vanB-E. faecium and vanB-E. faecalis were detected at 35, 12 and 5 hospitals, respectively. Genotype analysis revealed that all of the vancomycin-resistant E. faecium isolates obtained since 2005 belonged to ST78, and that clonally related vanB-E. faecalis of ST64 had spread to three hospitals. The rate of faecal VRE carriage among the patients enrolled in the annual surveillance increased until 2007, when it reached 24 (1.2%) of the 2,035 enrolled patients. The rate began to decrease in 2008 and, by 2010, reached a low of 4 (0.17%) of the 2,408 enrolled patients. While VRE did spread within the Kyoto region, the VRE control programme succeeded in controlling the overall VRE spread.

36 keywords...

hide…